Add BrightSurf on Google Email

INSERM (Institut national de la santé et de la recherche médicale)


A promising clinical trial to reduce the severity of autistic disorders

A clinical trial has shown that a diuretic can reduce the severity of autistic disorders in three-quarters of children. The treatment, which involves administering bumetanide to children with autism or Asperger's syndrome, has been found to improve symptoms such as social interaction and communication.

The radical restructuring of brain networks in comatose patients

Researchers found that comatose patients' brain networks are restructured in a radical way, with some regions becoming hubs and others less connected. This changes could be linked to consciousness disorders and may help clinical practitioners diagnose comatose patients more accurately.

SourceINSERM (Institut national de la santé et de la recherche médicale)·JournalProceedings of the National Academy of Sciences·DateDec 4, 2012

The H1N1 flu vaccine protects both pregnant women and newly-borns

A study of 107 pregnant women found that the H1N1 flu vaccine boosted their immune system and protected their newborns via transplacental transfer of antibodies. The results show that the influenza vaccine is safe during pregnancy and recommended for pregnant women to protect themselves and their babies.

Severe alcoholic hepatitis: An effective combination of 2 treatments

A new treatment combining corticosteroids and N-acetylcysteine improves survival rates for patients with acute alcoholic hepatitis by 35-40% within a month, compared to the conventional cortisone-based treatment. The study results show that this combination therapy is well-tolerated and offers a promising prognosis for severe alcoholic...

Neisseria meningitidis disseminates itself by sending out 'scouts'

Researchers at Inserm discovered that Neisseria meningitidis uses a strategy called 'scouting' to disperse from the throat into the bloodstream. This process involves the modification of pilin proteins with phosphoglycerol, which triggers dissemination and allows bacteria to colonize other areas of the throat and cross cell walls.

An end to lice: The effectiveness of a new oral treatment has been demonstrated

A new oral treatment has been shown to be effective in 95% of cases against head lice, providing a real therapeutic alternative to conventional anti-lice lotions. The study used oral Ivermectin administered at 400 μg per kilogram and found significant improvements compared to traditional malathion lotion treatments.